You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

low risk MDS

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplasia, Leukemia Trial in Providence (chemo)

Terminated
Has Results
  • Myelodysplasia
  • Leukemia
  • Providence, Rhode Island
    Lifespan Hospitals
Jan 5, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Bisantrene Dihydrochloride (high dose)
  • +3 more
  • Newcastle, New South Wales, Australia
    Calvary Mater
Jul 14, 2022

Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Trial in Worldwide (FG-4592, Placebo)

Active, not recruiting
  • Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)
  • Los Angeles, California
  • +71 more
Sep 16, 2022

Anemia Trial in Dresden (ACE-536)

Completed
  • Anemia
  • Dresden, Germany
    Acceleron Investigative Site
Apr 29, 2021

MDS Trial in Erlangen (Deferasirox (Novartis Pharma))

Terminated
Has Results
  • Myelodysplastic Syndromes
  • Deferasirox (Novartis Pharma)
  • Erlangen, Bavaria, Germany
    Medizinische Klinik 5, Universitätsklinikum Erlangen
Sep 11, 2020

Primary MDS Classified as Very Low, Low or Intermediate Risk With <5% Blasts Trial in China (FG-4592, Placebo)

Active, not recruiting
  • Primary MDS Classified as Very Low, Low or Intermediate Risk With <5% Blasts
  • Bengbu, Anhui, China
  • +37 more
Aug 17, 2022

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • +2 more
  • WT1:126-134
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021

MDS Trial in China, Japan (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
  • +33 more
Aug 16, 2022

MDS Trial in Dresden (ACE-536)

Completed
  • Myelodysplastic Syndromes
  • Dresden, Germany
    Acceleron Investigative Site
Apr 29, 2021

MDS Trial in France, Germany, United States (Oral rigosertib)

Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
Jun 15, 2021

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

MDS Trial (Hetrombopag)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
May 23, 2022

Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Brasschaat, Belgium
  • +9 more
Jan 19, 2023

MDS Trial in Chicago (Lenalidomide and azacitidine combination)

Terminated
Has Results
  • MDS
  • Lenalidomide and azacitidine combination
  • Chicago, Illinois
    Rush University Medical Center
Nov 2, 2020

MDS Trial in France, Germany (N-Plate / romiplostim)

Completed
  • Myelodysplastic Syndromes
  • N-Plate / romiplostim
  • Annecy, France
  • +35 more
Sep 7, 2021

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

MDS, Anemia Trial in Germany (Luspatercept Injection)

Recruiting
  • Myelodysplastic Syndromes
  • Anemia
  • Luspatercept Injection
  • Berlin, Germany
  • +18 more
Jan 25, 2023

Lower-risk Myelodysplastic Syndrome Trial in Tampa (JSP191)

Recruiting
  • Lower-risk Myelodysplastic Syndrome
  • Tampa, Florida
    Moffitt Cancer Center
Jun 20, 2023

MDS Over Time - Comparison of Treated vs Untreated Patients

Completed
  • Myelodysplastic Syndromes
    • Vienna, Austria
      Hanusch Krankenhaus, 3.Medizinische Abteilung
    Nov 21, 2022

    MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Luspatercept
    • Epoetin Alfa
    • Concord, California
    • +100 more
    Jul 20, 2023